Nick Mordwinkin
Corporate Officer/Principal at KEZAR LIFE SCIENCES, INC.
Net worth: - $ as of 29/04/2024
Profile
Nick Mordwinkin was the founder of Curium, a company founded in 2014, where he held the title of President from 2014 to 2016.
He is currently the Chief Business Officer at Kezar Life Sciences, Inc. since 2022.
Previously, he worked at Ultragenyx Pharmaceutical, Inc. from 2015 to 2020 as the Senior Director & Head-Corporate Strategy.
From 2020 to 2022, he was the Head-Development, Inflammation & Fibrosis at Gilead Sciences, Inc. Dr. Mordwinkin holds a doctorate degree from the University of Southern California and an undergraduate degree from Nova Southeastern University, Inc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
KEZAR LIFE SCIENCES INC
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 29/04/2024 |
Nick Mordwinkin active positions
Companies | Position | Start |
---|---|---|
KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | 10/07/2022 |
Former positions of Nick Mordwinkin
Companies | Position | End |
---|---|---|
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 31/05/2022 |
ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 30/09/2020 |
Curium | Founder | 30/11/2016 |
Training of Nick Mordwinkin
Nova Southeastern University, Inc. | Undergraduate Degree |
University of Southern California | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
KEZAR LIFE SCIENCES, INC. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
Private companies | 1 |
---|---|
Curium |
- Stock Market
- Insiders
- Nick Mordwinkin